Gynoveda
Gynoveda is an Indian FemTech company that sells FDA-certified Ayurvedic proprietary medicines and runs a 50+ clinic network to treat fertility, PCOS, menstrual disorders, and menopause for individual consumers across India via D2C e-commerce and physical clinics.
- Company typePrivate
- Founded2019
- HeadquartersMumbai, India
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Gynoveda does
Gynoveda Femtech Private Limited, founded in 2019 in Mumbai by Vishal Gupta and Rachana Gupta, is an Indian women's-health company that combines Ayurvedic proprietary medicines with technology, content, and community to address fertility, PCOS/PCOD, menstrual disorders, menopause, and male-factor infertility. Its core product line consists of FDA (Ayurveda)-certified proprietary tablet formulations (e.g., Jeehv for fertility, Myrha/Vamha for PCOS, Tula for irregular periods, Veera for heavy flow, Soma for white discharge, plus menopause tablets) sold direct-to-consumer at price points of ₹1,050–₹2,400 per product. The company runs a 4-step treatment protocol comprising a 40-minute doctor consultation covering 75+ health checks, customized Ayurvedic tablets, a Gynoveda diet plan, and ongoing follow-ups, supported by online fertility/period self-assessment tools.
Distribution is hybrid: a D2C e-commerce storefront (shop.gynoveda.com) with pan-India home delivery is paired with 50+ physical Ayurvedic fertility clinics across India staffed by 100+ doctors, supplemented by telemedicine consultations and call-center-based booking and follow-up. The company's go-to-market leans heavily on community-led acquisition through the Circle of Sisterhood Facebook group (1.2Lakh+ members), paid social on Facebook and Instagram, SEO/content marketing, and a brand ambassadorship with Bollywood actress Taapsee Pannu since 2023. The company has cumulatively served 6L+ (600,000+) customers, claims 20,000+ babies born naturally through its protocols, and cites clinical-outcome data including an 85% on-time ovulation rate in a 2023 EJPMR-published study. Funding to date totals approximately $11M ($1M seed in 2019 and $10M Series A in March 2023 led by India Alternatives Fund).
Gynoveda firmographics
Firmographics- Name
- Gynoveda
- Legal name
- Gynoveda Femtech Private Limited
- Website
- https://gynoveda.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Gynoveda is an Indian FemTech company that sells FDA-certified Ayurvedic proprietary medicines and runs a 50+ clinic network to treat fertility, PCOS, menstrual disorders, and menopause for individual consumers across India via D2C e-commerce and physical clinics.
- Ownership category
- akta.pro rank
Gynoveda industry classification
Industry- Product category
- Women's Healthcare Services
- NAICS
- Offices of Physicians (6211), Family Planning Centers (621410)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA)
- akta.pro secondary industries
- Fertility & Ovulation Products (OTC) (CRABAIAK), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)
Keywords
Where Gynoveda is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices9 records
Markets served
Gynoveda business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Marketing or Sales, Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Ayurvedic Medicine Sales: Direct-to-consumer sales of proprietary Ayurvedic tablets and supplements for fertility, PCOS, menstrual health, and menopause. Products are sold through the e-commerce website (shop.gynoveda.com) with home delivery across India. Individual product purchases ranging from ₹1,050 to ₹2,400.
- Clinic Consultation Services: Revenue from in-person and telemedicine doctor consultations at Gynoveda's network of 50+ clinics. Consultation fee is ₹2,000 which includes Ayurvedic assessment of 50+ health parameters, root cause analysis, diet suggestions, and personalized treatment guidance.
- Subscription/Repeat Purchases: Customers following multi-month treatment protocols (commonly 6-12 months) make repeat purchases of Ayurvedic medicines, creating recurring revenue from established patient relationships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Clinic Consultation - ₹2,000 |
| Unit Pricing | Pay-as-you-go | Fertility Support Products - ₹1,400 to ₹2,400 |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Gynoveda product offering
Product offeringCore offering
Gynoveda develops and sells proprietary FDA-certified Ayurvedic medicines for fertility, PCOS/PCOD, menstrual disorders, and menopause, paired with doctor consultations (40-minute sessions covering 75+ health checks). Products and consultations are delivered through a D2C e-commerce store (shop.gynoveda.com) with home delivery, a network of 50+ physical Ayurvedic fertility clinics across India, and telemedicine consultations.
Product overview
Gynoveda offers an integrated Ayurvedic women's healthcare platform combining proprietary Ayurvedic medicines with fertility clinics and digital tools. The core product portfolio includes named Ayurvedic tablet formulations (Jeehv, Myrha, Vamha, Tula, Veera, Soma) targeting fertility, PCOS, menstrual disorders, and menopause. Services are delivered through 50+ physical clinics across India and online consultations, supplemented by diet guidance, fertility/period tests, and the Circle of Sisterhood community. The treatment protocol follows a 4-step process: doctor consultation, Ayurvedic tablets, Gynoveda diet, and regular follow-up care.
Differentiator
Problem solved
Functional benefit
Products and services
- Fertility Support / Ovulation for Pregnancy (Jeehv) Ayurvedic tablets designed to improve egg quality and support healthy pregnancy; used by women/couples as part of Gynoveda's 4-step fertility treatment protocol.
- PCOS / PCOD Treatment Tablets Ayurvedic proprietary medicines formulated to reverse PCOS/PCOD and regulate monthly cycles, addressing 20+ gynecological disorders in women.
- Tula for Irregular Periods Ayurvedic tablets for delayed periods and lighter menstrual flow, helping women regulate their monthly cycles.
- Veera for Heavy Flow Ayurvedic tablets to regulate early periods and control heavy menstrual flow.
- Soma for White Discharge and Intimate Itching Ayurvedic tablets for treating intimate itching and white discharge issues in women.
- Ayurvedic Menopause Tablets Ayurvedic formulation to smooth menopause transition, manage weight gain, and reduce hot flashes for women approaching or experiencing menopause.
- Myrha and Vamha Combination Ayurvedic medicines used to regulate menstrual cycles and treat PCOS symptoms.
- Gynoveda Fertility Clinic Consultations In-person and online doctor-led Ayurvedic fertility consultations lasting 40 minutes and covering 75+ health checks, delivered across 50+ Gynoveda clinics and via telemedicine, producing personalized treatment plans with Ayurvedic tablets and diet guidance.
- Gynovedic Diet Personalized Ayurvedic diet and lifestyle program offered alongside Gynoveda's medicines to accelerate treatment results and support healthy pregnancy outcomes.
Quantifiable outcome
- 85% of women ovulated on time after Gynoveda treatment per clinical study published in European Journal of Pharmaceutical and Medical Research (EJPMR), 2023
- +6 more outcomes
Companies that use Gynoveda
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles5 records
Gynoveda technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Gynoveda partnerships and signals
Strategic signalScale indicators9 records
Recent moves7 records
Expansion highlights6 records
Gynoveda competitors and assessment
Company assessmentDirect peers
- Sirona Hygiene: Indian D2C women's health brand focused on menstrual hygiene, intimate care, and wellness products sold online. Most directly comparable as an Indian D2C femcare platform building category leadership with similar brand-led, content-and-community growth tactics.
- &Me (Anwin Investments): Indian women's nutrition and wellness D2C brand selling supplements targeting PCOS, periods, fertility, and hormonal health. Closely comparable in product category (OTC supplements for female reproductive and hormonal health) and D2C go-to-market motion in India.
- Pee Safe: Indian D2C femcare brand selling toilets-to-feminine hygiene and women's wellness products through e-commerce and offline retail. Comparable as one of India's first scaled women's health D2C brands with overlapping target customers and omnichannel distribution.
- Nua (Nua Woman): Indian women's wellness D2C brand offering personalized health packs for periods, PCOS, and intimate care. Direct peer in personalized, science-meets-wellness positioning for Indian women across menstrual and hormonal concerns.
Emerging players
- Veeda (formerly iCareBetter): Indian FemTech brand focused on natural and Ayurvedic solutions for fertility, PCOS, and menstrual health. Highly comparable in Ayurvedic product positioning and DTC women's health focus, though smaller in scale and clinic footprint.
- Avni (Conscious Chemist): Indian D2C feminine care and wellness brand offering intimate hygiene, menstrual, and pregnancy care products. Comparable in D2C women's health with a community-and-content-led growth approach targeting similar Indian female audiences.
- Carmesi: Indian D2C brand selling premium menstrual wellness products including pads and intimate care. Comparable as an emerging Indian FemTech brand focused on menstrual and intimate wellness through owned e-commerce and content.
Broad incumbents
- Practo: Largest Indian telehealth and doctor-discovery platform offering online consultations across specialties including gynecology and fertility. Relevant as a broader incumbent telemedicine incumbent whose online consultation model overlaps with Gynoveda's telemedicine channel.
- Patanjali Ayurved: India's largest Ayurvedic FMCG and wellness products company spanning foods, supplements, and Ayurvedic medicines. Relevant as a broad incumbent in the Ayurvedic products space that competes for the same consumer wallet on herbal wellness positioning.
- Nova IVF Fertility: India's largest chain of IVF and fertility clinics offering IVF, IUI, and other assisted reproductive technology services. Relevant as a broad-incumbent fertility-treatment alternative - Gynoveda explicitly positions against this ₹3-5 lakh IVF alternative with its Ayurveda-led approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Gynoveda social profiles
Digital presenceGynoveda compliance and trust
Trust signalCompliance2 records
Gynoveda financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gynoveda leadership team
Management profileNumber of profiles
Profiles3 records
Gynoveda funding detail
Funding detailFunding overview
Funding rounds2 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gynoveda M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gynoveda
What does Gynoveda do?
Gynoveda develops and sells proprietary FDA-certified Ayurvedic medicines for fertility, PCOS/PCOD, menstrual disorders, and menopause, paired with doctor consultations (40-minute sessions covering 75+ health checks). Products and consultations are delivered through a D2C e-commerce store (shop.gynoveda.com) with home delivery, a network of 50+ physical Ayurvedic fertility clinics across India, and telemedicine consultations.
Is Gynoveda a public or private company?
Gynoveda is a private company. It is classified as venture growth investor backed and is currently operating.
When was Gynoveda founded?
Gynoveda was founded in 2019. It employs 51 to 100 people.
Where is Gynoveda based?
Gynoveda is headquartered in Mumbai, India, in the Asia region.
How does Gynoveda make money?
Three revenue lines are on record. Ayurvedic Medicine Sales are the primary driver. The others are clinic Consultation Services and subscription/Repeat Purchases.
Who are Gynoveda's main competitors?
Direct peers on record are Sirona Hygiene, &Me (Anwin Investments), Pee Safe and Nua (Nua Woman). Emerging players are Veeda (formerly iCareBetter), Avni (Conscious Chemist) and Carmesi. Broad incumbents are Practo, Patanjali Ayurved and Nova IVF Fertility.
Does Gynoveda have an API?
No public API is recorded for Gynoveda.
What industry is Gynoveda in?
Gynoveda's product category is Women's Healthcare Services. Its primary akta.pro industry code is HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics, with a secondary code of CRABAIAK, Fertility & Ovulation Products (OTC). Its NAICS code is 6211 and its SIC code is 8011.